Russell Ray

Russell Ray is a seasoned investment professional with extensive experience in healthcare investment banking and management. Currently, Russell serves on the Investment Committee at Health Innovation Capital since January 2021 and holds the position of Senior Advisor at HLM Venture Partners, where Russell has been since March 2017. Russell's leadership experience includes serving as Chairman of the Audit and Finance Committee at Merrimack Pharmaceuticals since April 2014, and previously, Russell was Vice Chairman and Managing Director at Stifel, Nicolaus & Company from January 2016 to February 2017. Russell's prior roles include Partner at HLM Venture Partners, Managing Director at Credit Suisse First Boston and BT Alex. Brown, and Managing Director at Alex. Brown Inc., among others. Russell earned an MS/MBA from the University of Pennsylvania and Bachelor’s degrees in Zoology/Animal Biology and Engineering from the University of Washington and the United States Military Academy at West Point, respectively.